Alluvi tirzepatide has been emerged as a promising therapeutic option for the management of metabolic conditions. This preclinical evaluation explored the efficacy and profile of tirzepatide 40mg in experimental models of type 2 diabetes. The research demonstrated that tirzepatide 40mg substantially improved glycemic control and reduced insulin res